RARE (Ultragenyx Pharmaceutical Inc.) Bathi sing dikarepake

Logo grafis Ultragenyx Pharmaceutical (RARE)

Ultragenyx Pharmaceutical brings together leading geneticists developing life-saving therapies for rare pathologies. The expected profit margin illustrates the market reaction to this potential, where the indicator value is 0.01. The growth of Crysvita and a promising pipeline are driving a revaluation of the asset, although strict FDA oversight and a small patient population create certain financial pressure on the company.

RARE: Proyeksi bathi mangsa ngarep Ultragenyx Corp 05.11.2026 - 18.11.2026

Rincian metrik lan analitis perusahaan Ultragenyx Corp (RARE)

Analisis umum perusahaan:Ultragenyx Corp
Produk dadi Ultragenyx Pharma

This indicator aggregates market expectations for future net income, neutralizing reporting time lags to provide a real-time assessment of the asset's fundamental value. The trend in the projected profit levels of Ultragenyx Pharmaceutical (RARE) reflects the company's sensitivity to geopolitical risks and biocomponent supply chain disruptions, allowing investors to anticipate the impact of logistical constraints on business capitalization through the lens of forecasted earnings.

Pesaing Ultragenyx Pharmaceutical

Bathi sing dikarepake Tempus AI|Proyeksi bathi mangsa ngarep Qiagen|Proyeksi bathi mangsa ngarep IONS|Bathi sing dikarepake RGEN (Repligen Corp.)|Avidity - Bathi mangsa ngarep|CRSP (crisprtx.com) - Bathi forward|WGS: Bathi mangsa ngarep|Beam Therapeutics - Bathi resik mangsa ngarep|SRPT: Proyeksi bathi mangsa ngarep|TWST (Twist Bio) - Bathi sing dikarepake|TXG (10xgenomics.com) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep Intellia Therapeutics, Inc.|Proyeksi bathi mangsa ngarep STOK|Prakiraan bathi perusahaan BioLife Solutions Inc|Bathi sing dikarepake Wave Pharma WVE|Proyeksi bathi mangsa ngarep Maze Therapeutics Corp MAZE|SION - Bathi sing dikarepake|Prime Medicine, Inc. (PRME) - Bathi mangsa ngarep|TSHA (Taysha Gene Therapies, Inc.) - Bathi mangsa ngarep|QURE - Prakiraan bathi perusahaan|MGTX (MeiraGTx Holdings plc) - Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep REGENXBIO Inc. (RGNX)|Bathi sing dikarepake Solid Biosciences (SLDB)|ocugen.com (OCGN) - Proyeksi bathi resik|Proyeksi bathi mangsa ngarep PACB (PacBio Corp)|Penghasilan resik sing dikarepake BNTC|DSGN: Bathi mangsa ngarep|RCKT - Proyeksi bathi mangsa ngarep|Penghasilan resik sing dikarepake 4D Molecular Corp FDMT|Bathi mangsa ngarep Lexeo|Bathi sing dikarepake Korro Bio Inc.|Prakiraan bathi resik EDIT (Editas Medicine)|Bathi sing dikarepake Silence Therapeutics Corp (SLN)|PRQR (ProQR) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep CDXS (Codexis, Inc.)|Prakiraan bathi perusahaan sangamo.com (SGMO)|nautilus.bio - Proyeksi bathi mangsa ngarep|Metagenomi (MGX) - Bathi mangsa ngarep|DTIL: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Generation Bio Co (GBIO)|BOLD (Boundless Bio) - Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep Exicure (XCUR)|Bathi sing dikarepake Celsion Corporation (IMNN)|PHIO - Bathi resik sing dikarepake|Mustang Bio Inc - Bathi mangsa ngarep|Proyeksi bathi mangsa ngarep transcodetherapeutics.com RNAZ|Bionano Genomics Inc. - Proyeksi bathi mangsa ngarep|APDN (Applied DNA Sciences) - Prakiraan bathi resik|BLUE (bluebirdbio.com) - Bathi mangsa ngarep|Prakiraan bathi resik IPA|OMGA (omegatherapeutics.com) - Proyeksi bathi mangsa ngarep|Singular Genomics Systems Inc (OMIC) - Prakiraan bathi perusahaan|Proyeksi bathi mangsa ngarep RGLS|Prakiraan bathi perusahaan Syros Pharmaceuticals, Inc.|Bathi sing dikarepake Telesis Bio Inc. TBIO|Bathi resik mangsa ngarep TCON (TRACON Pharmaceuticals Inc.)|Unity Bio - Proyeksi bathi mangsa ngarep